Hyperinsulinemia in psychiatric patients treated with olanzapine.
Cohn
Tony A
TA
Remington
Gary
G
Kameh
Homa
H
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D001786:Blood Glucose / Q000032:analysis; D005215:Fasting / Q000097:blood; D005260:Female; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood / Q000139:chemically induced*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008297:Male; D001523:Mental Disorders / Q000097:blood / Q000188:drug therapy*; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D014150:Antipsychotic Agents; D001786:Blood Glucose; D007328:Insulin; D014280:Triglycerides; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine